CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award | +155 | 6,703 | ||
| 2026-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,962 | 1,962 | ||
| 2025-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award | +166 | 6,548 | ||
| 2025-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,958 | 1,958 | ||
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Exercise or conversion 10b5-1 | +2,707 | $625.60 | $1.7M | 9,089 |
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Sale 10b5-1 | −2,707 | $950.00 | $2.6M | 6,382 |
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −2,707 | 0 | ||
| 2024-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award | +135 | 6,382 | ||
| 2024-01-02 | GOLDSTEIN JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,607 | 1,607 | ||
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +3,613 | $482.68 | $1.7M | 9,860 |
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Sale | −3,613 | $800.00 | $2.9M | 6,247 |
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,613 | 0 | ||
| 2023-01-03 | GOLDSTEIN JOSEPH L Director | Grant or award | +165 | 6,247 | ||
| 2023-01-03 | GOLDSTEIN JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,929 | 1,929 | ||
| 2022-03-30 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +2,431 | $374.12 | $909K | 8,513 |
| 2022-03-30 | GOLDSTEIN JOSEPH L Director | Sale | −2,431 | $700.00 | $1.7M | 6,082 |
| 2022-03-30 | GOLDSTEIN JOSEPH L Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,431 | 0 | ||
| 2022-01-03 | GOLDSTEIN JOSEPH L Director | Grant or award | +191 | 6,082 | ||
| 2022-01-03 | GOLDSTEIN JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,707 | 2,707 | ||
| 2021-09-10 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +2,479 | $380.95 | $944K | 8,370 |
Page 1 of 4 · 75 trades